InMode (NASDAQ:INMD) Sets New 12-Month Low – Time to Sell?

Shares of InMode Ltd. (NASDAQ:INMD) hit a new 52-week low during mid-day trading on Monday . The company traded as low as $12.95 and last traded at $12.9830, with a volume of 502175 shares. The stock had previously closed at $13.23.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on INMD shares. BTIG Research reaffirmed a “neutral” rating on shares of InMode in a research note on Monday, January 26th. Canaccord Genuity Group set a $15.00 price target on InMode and gave the stock a “hold” rating in a research note on Wednesday, December 17th. Robert W. Baird set a $17.00 price target on InMode in a report on Wednesday, February 11th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of InMode in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, InMode has a consensus rating of “Hold” and an average price target of $16.80.

InMode Price Performance

The stock has a market cap of $820.83 million, a P/E ratio of 9.00 and a beta of 2.18. The company has a fifty day moving average of $14.56 and a 200 day moving average of $14.68.

InMode (NASDAQ:INMD) last issued its quarterly earnings results on Tuesday, February 10th. The healthcare company reported $0.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.42 by $0.04. InMode had a return on equity of 14.52% and a net margin of 25.33%.The firm had revenue of $103.85 million during the quarter, compared to analyst estimates of $104.64 million. During the same period last year, the company posted $0.42 EPS. The firm’s quarterly revenue was up 6.1% on a year-over-year basis. As a group, analysts anticipate that InMode Ltd. will post 1.75 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of INMD. Leonteq Securities AG acquired a new position in InMode during the fourth quarter worth about $26,000. Quadrant Capital Group LLC lifted its holdings in InMode by 127.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,945 shares of the healthcare company’s stock valued at $29,000 after acquiring an additional 1,091 shares during the last quarter. Advisory Services Network LLC bought a new position in shares of InMode during the 3rd quarter valued at about $37,000. Basepoint Wealth LLC bought a new position in shares of InMode during the 4th quarter valued at about $39,000. Finally, Blue Trust Inc. grew its stake in shares of InMode by 93.7% in the 3rd quarter. Blue Trust Inc. now owns 2,861 shares of the healthcare company’s stock worth $43,000 after purchasing an additional 1,384 shares during the last quarter. Institutional investors own 68.04% of the company’s stock.

About InMode

InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.

InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.

The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.